Cancer metastasis occurs through a series of sequential steps, which involves dissemination of tumor cells from a primary site and colonization in distant tissues. To promote the invasion-metastasis cascade, carcinoma cells usually initiate a cell-biological program called epithelial-mesenchymal transition (EMT), which is orchestrated by a set of master regulators, including TGF-β, Snail, ZEB and Twist families. The biological activities of these molecules are tightly regulated by a variety of cell-intrinsic pathways as well as extracellular cues. Recently, accumulating evidence indicates that long non-coding RNAs (lncRNAs) represent some of the most differentially expressed transcripts between primary and metastatic cancers. LncRNAs including MALAT1, HOTAIR, H19, LncRNA-ATB, and LincRNA-ROR have been reported to be involved in the process of EMT, mainly through cross-talking with master regulators of EMT. Thus, understanding the different and precise molecular mechanisms by which functional lncRNAs switch EMT on and off is important for opening up new avenues in lncRNA-directed diagnosis, prognosis, and therapeutic intervention against cancer.
Missing Links in Epithelial-

Introduction
The epithelial-mesenchymal transition (EMT), initially recognized as essential during embryonic development, has more recently been implicated in promoting carcinoma invasion and metastasis. The full accomplishment of the EMT process requires a complex genetic program that, together with the loss of the epithelial character, implies the acquisition of mesenchymal and motility properties. EMT can be exploited by normal or HuR, MALAT1 binds the CD133 promoter region to repress its expression and suppresses EMT in breast cancer (Fig. 2b , ii) [33] . Thus, further studies are necessary to understand the precise role of MALAT1 in EMT and metastasis and the molecular determinants of its function.
HOTAIR HOX transcript antisense intergenic RNA (HOTAIR), one of the first lncRNAs described to have a fundamental role in cancer metastasis, is located in the HOXD locus and exhibits cell-type and tissue-specific expression patterns [34] . HOTAIR expression is upregulated in malignant tissues and is associated with an increase in invasion and metastasis in breast, lung, colorectal, and hepatocellular carcinoma [35] [36] [37] [38] . Mechanistic study revealed that enforced expression of HOTAIR in epithelial cancer cells induced genome-wide re-targeting of Polycomb repressive complex 2 (PRC2) to an occupancy pattern more resembling embryonic fibroblasts, leading to altered histone H3 lysine 27 methylation and gene expression [35] . Similar to MALAT1, recent data demonstrated that HOTAIR overexpression is also closely related to enhanced EMT characteristics. A study conducted by Padua et al. revealed that HOTAIR is required for EMT and stemness maintenance of cancer cell lines [39] . They found that treating cells with transforming growth factor-beta (TGF-β) resulted in increased HOTAIR expression and triggered the EMT program, while ablation of HOTAIR expression by siRNA prevented the EMT program stimulated by TGF-β1. In another study conducted in colon cancer cell lines, Wu et al. found that depletion of HOTAIR led to increased expression of E-cadherin and downregulation of Vimentin and MMP9, suggesting that HOTAIR may be a pleiotropic modulator participating in EMT [40] . Further study revealed that HOTAIR-PRC2 complex epigenetically silences a tumor-suppressive microRNA miR-34a, which controls the downstream targets c-Met (HGF/c-Met/Snail pathway) and Snail, thus contributing to the process of EMT and tumor metastasis in gastric cancer (Fig. 2b, i) [41] . Moreover, Wu et al. demonstrated that HOTAIR contributes to the direct suppression of E-cadherin by recruiting enhancer of zeste homolog 2 (EZH2) to the E-cadherin promoter [42] . Supporting evidence were found that HOTAIR expression levels were negatively correlated with those of E-cadherin in gastric cancer and oral squamous cell carcinoma tissues [41, 42] . Besides, Hong et al. demonstrated that HOTAIR also functions as a ceRNA for miR-217, thus regulating HIF-1α/AXL signaling and promoting EMT process in renal cell carcinoma [43] . Despite much progress in recent years, our knowledge of the relationship between HOTAIR and EMT is still unsatisfactory and further studies are necessary to understand the precise role of HOTAIR in the process of EMT.
H19
The H19 gene belongs to a highly conserved imprinted gene cluster that plays important roles in embryonal development and growth control. H19 expression is strongly induced during embryogenesis and downregulated after birth, except in adult skeletal muscle and heart. Over the last decade, a role for H19 acting either as a tumor suppressor [44] or an oncogene [45] has been reported. Since then, accumulating evidence suggests that H19 is also significantly associated with EMT process and tumor metastasis. In a study conducted in hepatocellular carcinoma (HCC), Zhang et al. revealed that H19 associates with the protein complex hnRNP U/PCAF/RNApol II and activates miR-200 family (pivotal repressors of EMT [46] ) by increasing histone acetylation, thus contributing to mesenchymal-to-epithelial transition (MET) and suppression of tumor metastasis [47] . In another study conducted in prostate cancer, Zhu et al. found that H19 and H19-derived miR-675 were significantly downregulated in the metastatic prostate cancer cell line compared with the non-metastatic prostate epithelial cell line. Ectopic expression of H19 resulted in increased level of miR-675, which directly binds to the 3'UTR of TGFBI (an extracellular matrix protein involved in EMT and cancer metastasis) mRNA to repress its translation [48] . However, several other works demonstrated that H19 may promote the EMT process rather than impeding it [49, 50] . Luo et al. found that H19 levels are remarkably upregulated in bladder cancer tissues, and ectopic expression of H19 promotes bladder cancer cell migration in vitro and in vivo. Mechanistic study demonstrated that H19 is associated with EZH2, which results in Wnt/β-catenin activation and subsequent repression of E-cadherin [49] . Moreover, Matouk et al. found that H19 expression level was tightly correlated with tumor metastatic potential and numerous established inducers of EMT (such as TGF-β and hypoxia) could upregulate H19 and miR-675 concomitantly with the induction of EMT markers. Through a mechanism involving miR-675, H19 upregulated Slug expression and decreased E-cadherin protein level. Interestingly, Slug also activated the promoter of H19 gene and upregulated its expression, thus forming a positive feedback loop between Slug and H19/miR-675, which regulates E-cadherin expression [50] . In a recent study, Zhou et al. revealed that H19 could mediate breast cancer cell plasticity during the EMT and MET processes by differentially sponging miR-200b/c and let-7b [51] . Taken together, the above data suggest that the functional role that H19 exerts in EMT and tumor metastasis is context-dependent and should be investigated carefully.
LncRNA-ATB
LncRNA activated by TGF-β (LncRNA-ATB) was recently described to promote the invasion-metastasis cascade in HCC [52] . As its name suggests, LncRNA-ATB is induced by TGF-β in multiple cancer types, including breast, colorectal, gastric, and hepatocellular carcinoma [52] [53] [54] [55] . LncRNA-ATB plays an essential role in both the early-stage invasion process and the late-stage colonization phase of metastasis in vivo [52] . Mechanistic study demonstrated that the functional role that LncRNA-ATB plays in early-stage invasion is closely related to the EMT process. By competitively binding the miR-200 family, LncRNA-ATB upregulated ZEB1 and ZEB2 expression and then induced EMT (Fig. 2b, iii) . Depletion of LncRNA-ATB abrogated TGF-β-induced EMT in vitro and decreased the number of circulating tumor cells (CTCs) in whole blood from orthotopic tumor models in vivo, in a miR-200-dependent manner. However, miR-200 overexpression only partially rescued LncRNA-ATBinduced metastasis in vivo, indicating the involvement of additional downstream players. Indeed, LncRNA-ATB stabilized interleukin-11 (IL-11) mRNA and elevated IL-11 secretion, thus activating STAT3 signaling which promotes organ colonization of disseminated tumor cells [52] . In another study conducted in HER2-positive breast cancer, Shi et al. found that LncRNA-ATB was remarkably upregulated in trastuzumab-resistant breast cancer cell lines and tissues. They demonstrated that LncRNA-ATB could promote trastuzumab resistance and invasion-metastasis cascade in HER2-positive breast cancer by competitively binding miR-200c, thus upregulating ZEB1 and ZNF-217, and then inducing EMT [53] . Despite much progress in recent years, our knowledge of the relationship between LncRNA-ATB and EMT is still limited and further studies are necessary to understand the versatile roles exerted by LncRNA-ATB.
LincRNA-ROR
First identified as a lincRNA whose expression is linked to pluripotency [56] , lincRNAregulator of reprogramming (LincRNA-ROR) is now considered to play a crucial role in the process of EMT and tumor metastasis. High expression of LincRNA-ROR is observed in multiple cancer types, including breast, bladder, and nasopharyngeal carcinoma [57] [58] [59] . Ectopic expression of LincRNA-ROR in cancer cells was associated with enhanced migration, invasion and EMT in vitro and metastasis in vivo. Mechanistically, The EMT-promoting effects of LincRNA-ROR are mostly attributed to its function as a miRNA sponge for several key miRNAs. One such miRNA is miR-205, a tumor-suppressive miRNA which targets ZEB1 and ZEB2. Silencing of LincRNA-ROR promoted the degradation of miR-205 target genes, resulting in impaired EMT and metastatic potential [57] . miR-145, a well-known miRNA commonly downregulated in various cancers [60] , is another miRNA that can be competitively absorbed by LincRNA-ROR. In a study conducted in triple-negative breast cancer, Eades et al. found that LincRNA-ROR could competitively bind miR-145, which targets small GTPase ADPribosylation factor 6 (ARF6), leading to enhanced endocytosis of E-cadherin and reduced cell-cell adhesion [61] . It is worth noting that LincRNA-ROR transcripts were quite abundant Cellular Physiology and Biochemistry
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in the cytoplasm of self-renewing embryonic stem cells (ESCs) [62] , which supports the hypothesis that LincRNA-ROR interacted with miRNAs in the cytoplasm. However, other potential mechanisms underlying the EMT-promoting effects of LincRNA-ROR are likely to be involved and deserve further investigation in the near future (Table 1) .
Crosstalk between EMT regulators and lncRNAs
TGF-β and LncRNAs
The multifunctional cytokine TGF-β orchestrates an intricate signaling network to modulate tumorigenesis and progression. TGF-β exerts its tumor-suppressive role by inducing cell-cycle arrest and apoptosis. Nevertheless, TGF-β also promotes tumor progression through enhancing proliferation, migration, and invasion, in part by its ability to induce EMT [116] . Recent evidence, addressing the crosstalk between the TGF-β signaling pathway and lncRNAs in cancer, found that several members of the TGF-β pathway are Cellular Physiology and Biochemistry
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targeted by lncRNAs, and the production of hundreds of lncRNAs is induced by TGF-β treatment (Fig. 2a) . For example, Li et al. showed that knockdown of MALAT1 could inhibit TGF-β production by modulating recruitment of transcription factor Sp1 to the LTBP3 gene promoter in mesenchymal stem cells from patients with multiple myeloma [117] . In addition, Fan et al. reported that TGF-β could also induce MALAT1 expression and EMT in bladder cancer cells and targeted inhibition of MALAT1 suppressed the migratory and invasive properties induced by TGF-β [27] . Maternally expressed gene 3 (MEG3), located in the imprinted DLK1-MEG3 locus on human chromosome 14q32.3, is another key lncRNA which could regulate TGF-β pathway through epigenetic mechanisms. In a study conducted in breast cancer, Mondal et al. found that MEG3 and EZH2 share common target genes, including the TGF-β pathway genes. Genome-wide mapping of MEG3 binding sites revealed that MEG3 modulates the activity of TGF-β genes by binding to distal regulatory elements. MEG3 binding sites have GA-rich sequences, which guide MEG3 to the chromatin through RNA-DNA triplex formation [118] . Moreover, several other lncRNAs were reported to regulate the TGF-β signaling pathway in a variety of different ways, including plasmacytoma variant translocation 1 (PVT1), p53 induced non-coding transcript (PINT), and Linc00974. Takahashi et al. demonstrated that PVT1 knockdown could upregulate Smad4 and apoptosisassociated genes related to the TGF-β pathway [119] . Marin-Bejar et al. revealed that PINT could promote cell proliferation and survival by regulating the expression of genes of the TGF-β, MAPK and p53 pathways in mouse cells [120] . Linc00974 was reported to be involved in a Linc00974-miR-642-KRT19-TGF-β signaling pathway [121] . In this study, Tang et al. revealed that Linc00974 hyperexpression could induce the upregulation of KRT19 via ceRNA network, resulting in the activation of the TGF-β and Notch pathways as detected by cDNA microarray. Although our current knowledge on the complex role of lncRNAs in TGF-β signaling pathways is poor, the lncRNAs remain of great therapeutic potential for antagonizing the deregulation of TGF-β pathway in cancer. Further studies of the lncRNA-TGF-β signaling network will definitely help expand our understanding of the pathogenesis of human malignancies.
Snail/Slug and LncRNAs
Of the three vertebrate Snail proteins, Snai1 (also known as Snail) and Snai2 (also known as Slug) activate the EMT pro gramme during development, fibrosis and cancer [122] . Snail factors bind to E-box consensus sequences in the E-cadherin promoter with the help of local modifications of chromatin structure after the recruitment of SIN3A, histone deacetylases HDAC1 and HDAC2, and components of PRC2 complex. In addition to being tightly regulated at the transcriptional level, Snail factors undergo posttranslational modifications that control their nuclear localization or degradation [123] . In recent years, accumulating evidence suggests that Snail factors and lncRNAs could regulate each other reciprocally, thus adding another layer of complexity to the regulation of Snail activity (Fig. 2a) . Orom et al. found that a set of lncRNAs exhibit enhancer-like function in human cell lines, and depletion of some of these lncRNAs led to decreased expression of their neighboring protein-coding genes, such as Snail and Slug [124] . It was reported previously that Snail protein could recruit chromatin modifier EZH2 to a broad repertoire of epithelial genes but the underlying mechanism remains largely unknown [125] . Recently, Battistelli et al. revealed that HOTAIR mediates a physical interaction between Snail and EZH2 and the Snail-repressive activity depends on the formation of a tripartite Snail/HOTAIR/EZH2 complex [126] . In a TGF-β-induced EMT model, Matouk et al. demonstrated that H19 could upregulate Slug expression concomitant with the suppression of E-cadherin protein through a mechanism involving miR-675. In turn, Slug also bound and activated the promoter of H19 to upregulate its expression, thus forming a positive feedback loop between Slug and H19/miR-675 [50] . Besides H19, several other lncRNAs are now reported to play a pivotal role in regulating the expression and activity of Snail factors, such as LINC01013 [127] , lnc-GNAT1-1 [128] , and Lnc-CC3 [129] . However, our current knowledge of the crosstalk between lncRNAs and Snail factors is still limited and further studies are necessary to understand the precise relationship between them.
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ZEB and LncRNAs
Like Snail proteins, ZEBs bind E-boxes and function as transcriptional repressors and activators, thereby repressing some epithelial junction and polarity genes and activating mesenchymal genes that define the EMT phenotype. ZEB expression often follows activation of Snail expression, consistent with Snail directly target ing the ZEB1 gene. Besides, numerous studies have reported that ZEB factors can also be regulated by other mechanisms such as miRNA-mediated gene silencing and Polycomb-mediated sumoylation [122] . Interestingly, recent work showed that lncRNAs are involved in regulation of ZEB in a variety of different ways (Fig. 2a) . First, lncRNAs could upregulate ZEB expression via ceRNA regulatory networks. As mentioned above, Yuan et al. demonstrated that LncRNA-ATB upregulates ZEB1 and ZEB2 expression by competitively binding the miR-200 family, thus contributing to the EMT process (Fig. 2b, iii) [52] . ZFAS1, a lncRNA that is frequently amplified in HCC, functions as an oncogene in HCC progression by binding miR-150, thus derepressing its inhibitory effect on ZEB1 [113] . Moreover, Hou et al. found that LincRNA-ROR is associated with miRNPs and functions as a ceRNA for miR-205. Specifically, LincRNA-ROR prevents the degradation of miR-205 target genes, including the EMT inducer ZEB2 [57] . Secondly, lncRNAs could upregulate ZEB expression via enhancer-like mechanisms. In a study conducted in HCC, Li et al. revealed that an lncRNA named ZEB1-AS1 is frequently upregulated in HCC samples, especially in metastatic tumor tissues. The ZEB1-AS1 gene is located in physical contiguity with ZEB1 and positively regulates the ZEB1 expression. ZEB1 depletion partially abrogates ZEB1-AS1-induced EMT and tumor metastasis, suggesting ZEB1-AS1 and ZEB1 play a critical role in HCC progression [111] . Thirdly, lncRNAs also contribute to pathogenic splicing of ZEB genes. Beltran et al. found that maintenance of 5'- UTR ZEB2 intron is dependent on the expression of a natural antisense transcript (NAT) that overlaps the 5' splice site in the intron. Ectopic overexpression of NAT in epithelial cells prevents splicing of the ZEB2 5'-UTR, increases the levels of ZEB2 protein, and consequently downregulates E-cadherin mRNA and protein [130] .
Twist and LncRNAs
As with Snail, Twist expression downregulates epi thelial gene expression and activates mesenchymal gene expression. In cancer cells, Twist1 represses E-cadherin and induces N-cadherin expres sion independently of Snail and probably through the association with other proteins. Recent study showed that more than 99 lncRNAs and 3164 genes are differentially expressed in the Twist-induced EMT process, suggesting that Twist contributes to invasion and metastasis by inducing wide-ranging transcriptional and functional changes of lncRNAs and signaling pathways [131] . Zou et al. found that lncRNA-Hh, transcriptionally regulated by Twist, directly targets GAS1 to stimulate the activation of hedgehog signaling, thus endowing Twist-induced EMT cells to gain the cancer stem cell-like stemness properties [86] . Moreover, several reports showed that lncRNAs could in turn regulate Twist expression in multiple cancer types. In a study conducted in gastric cancer, Cai et al. demonstrated that FRLnc1 overexpression could promote cancer cell migration and metastasis and identified TGF-β1 and Twist as the downstream effectors of FRLnc1 [132] . In CRC, Niu et al. revealed that AK027294 downregulation significantly inhibited CRC cell migration and promoted cell apoptosis by regulating Twist, caspase-3, caspase-8, Bcl-2, MMP12, MMP9 expression [133] . In gallbladder cancer, LincRNA-ROR and AFAP1-AS1 are also reported to regulate Twist expression to promote EMT process [134, 135] . Previous work demonstrated that lncRNAs could directly interact with proteins to function as scaffolds for chromatin-remodeling complexes or other regulatory complexes [136] . One recent study showed that, an lncRNA named HOTTIP, could form a complex with Twist and WDR5, leading to the upregulation of HOXA9 and aggressive cellular phenotypes such as invasion and migration [78] . Together, these data suggest that the crosstalk between Twist and lncRNAs is rather complex and further studies are needed to investigate the more detailed underlying mechanisms.
Conclusion
EMT is a complex, multifunctional, and tightly regulated process that plays anessential role in tumor metastasis. EMT-activating signaling pathways and EMT-inducing transcription factors (EMT-TFs) are responsible for driving EMT and conferring aggressive mesenchymal properties to epithelial cells. Over the past few years, lncRNAs, which belong to a novel heterogeneous class of ncRNAs, are emerging as promising biomarkers and therapeutic targets for EMT and metastasis. Accumulating evidence has indicated that lncRNAs are widely dysregulated in a variety of malignancies to impact epithelial plasticity by targeting different signaling pathways, EMT-TFs, and EMT-related genes. The distribution and levels of lncRNAs in various locations such as distal metastases, have been exploited as potential diagnostic and prognostic biomarkers for cancer. Technologies have been advanced to achieve more sensitive and reliable detection and effective targeting of lncRNAs for cancer treatment. Despite these advances, there remain many challenges, such as limited knowledge of lncRNA functional mechanisms, targets, and binding partners, the challenges of effective delivery, stability, immunogenicity, and bioavailability of lncRNA-targeted therapeutics, all of which will be formidable tasks to undertake for the future studies. Overall, lncRNAs have shed new light on our understanding of cancer pathways and brought our understanding of tumorigenesis to a new horizon. Understanding the different and precise molecular mechanisms by which functional lncRNAs switch EMT on and off is important for opening up new avenues in lncRNA-directed diagnosis, prognosis, and therapeutic intervention against cancer. 
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